Our press releases

Filter by : date
Diabeloop study reveals significative sex differences in insulin requirements for Type 1 diabetes patients
  • Jul 16, 2024
Nouvelle levée de fonds de 15 millions d’euros pour Diabeloop qui annonce la nomination de François Miceli au poste de Président et Directeur Général
  • Mar 26, 2024
Diabeloop announces collaboration with Novo Nordisk to pursue its interoperability strategy with connected insulin pens – A dedicated clinical program will assess the efficacy of the combined technologies
  • Mar 21, 2023
Diabeloop: launch of a multi-country clinical study in adolescents and young adults with T1D – Unannounced Meal Management efficacy key to a better quality of life for people with diabetes
  • Feb 23, 2023
Diabeloop and EOFlow partner to offer a Wearable AID with a Smartphone App
  • Jan 12, 2023
12-month real-world achievements for Diabeloop’s AID: – 4 million hours of hypoglycemia avoided – Trust in the algorithm leads to fewer meal declarations – Users report a significantly reduced mental load
  • Sep 21, 2022
Diabeloop, key player in therapeutic AI applied to insulin delivery, announces 70 million euros new financing round to accelerate its international expansion
  • Jun 02, 2022
Confirmed improvement in Time In Range +18.4 percentage points – Reduction of time spent in hypoglycemia to only 0.9% – Diabeloop presents new real-life results of DBLG1® System
  • Apr 27, 2022
Diabeloop adapts its self-learning, personalized insulin automatization software to be used with insulin pens
  • Apr 12, 2022
Terumo Corporation and Diabeloop SA. Enter into Comprehensive Strategic Partnership Agreement to Expand Their Diabetes Care Offerings
  • Nov 15, 2021
Significant improvement in increasing Time In Range and reducing hypoglycemia among people equipped with Diabeloop DBLG1
  • Sep 28, 2021
Diabeloop joins the AACE Corporate Advisory Program, Appoints US Scientific Advisors
  • Sep 16, 2021
DBLG1 self-learning algorithm: easy to use for optimized and personalized T1D management
  • Jun 02, 2021
BIOCORP and Diabeloop announce co-development agreement in personalized diabetes management
  • Mar 22, 2021
Diabeloop integrates the Accu-Chek Insight insulin pump from Roche into its Automated Insulin Delivery System
  • Mar 01, 2021
Diabeloop appoints Catherine Dunand Chairman of the Board
  • Jan 20, 2021
Diabeloop SA. and SFC Fluidics Inc. announce development agreement for the United States
  • Jan 07, 2021
Diabeloop introduces an automated management solution for highly unstable diabetes
  • Nov 26, 2020
Diabeloop SA. and Terumo Corporation enter into joint development agreement with exclusive distribution right for DBLG1® automated insulin delivery solution in Japanese market
  • Nov 16, 2020
Diabeloop expands its presence in Germany
  • Jun 26, 2020
Diabeloop launched a large clinical study to support its iController’s FDA clearance
  • Feb 20, 2020
Diabeloop Completes Record-Breaking European Fundraising Effort With Its Autonomous Diabetes Management Solutions
  • Dec 02, 2019
For World Diabetes Day Diabeloop is celebrating life without interruptions!
  • Nov 14, 2019
“The Lancet Digital Health” publishes positive results of the clinical trial with Diabeloop’s system in real life
  • May 15, 2019
Diabeloop and ViCentra announce European distribution partnership
  • Apr 09, 2019
Diabeloop at CES in Las Vegas from January 8 to 11: its groundbreaking innovation
  • Dec 17, 2018
Diabeloop obtains CE marking and launches new round of funding
  • Nov 07, 2018